240 related articles for article (PubMed ID: 32821247)
1. LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1.
Chen QH; Li B; Liu DG; Zhang B; Yang X; Tu YL
Cancer Cell Int; 2020; 20():394. PubMed ID: 32821247
[TBL] [Abstract][Full Text] [Related]
2. KCNQ1OT1 sponges miR-34a to promote malignant progression of malignant melanoma via upregulation of the STAT3/PD-L1 axis.
Wang X; Ren Z; Xu Y; Gao X; Huang H; Zhu F
Environ Toxicol; 2023 Feb; 38(2):368-380. PubMed ID: 36399467
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
Wang QM; Lian GY; Song Y; Huang YF; Gong Y
Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
[TBL] [Abstract][Full Text] [Related]
4. LncRNA KCNQ1OT1 Secreted by Tumor Cell-Derived Exosomes Mediates Immune Escape in Colorectal Cancer by Regulating PD-L1 Ubiquitination
Xian D; Niu L; Zeng J; Wang L
Front Cell Dev Biol; 2021; 9():653808. PubMed ID: 34350172
[No Abstract] [Full Text] [Related]
5. miR-15a and miR-15b modulate natural killer and CD8
Pathania AS; Prathipati P; Olwenyi OA; Chava S; Smith OV; Gupta SC; Chaturvedi NK; Byrareddy SN; Coulter DW; Challagundla KB
Mol Ther Oncolytics; 2022 Jun; 25():308-329. PubMed ID: 35663229
[TBL] [Abstract][Full Text] [Related]
6. LncRNA KCNQ1OT1 knockdown inhibits viability, migration and epithelial-mesenchymal transition in human lens epithelial cells via miR-26a-5p/ITGAV/TGF-beta/Smad3 axis.
Liu J; Dong Y; Wen Y; Shi L; Zhu Z; Ke G; Gu Y
Exp Eye Res; 2020 Nov; 200():108251. PubMed ID: 32950535
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-15a Carried by Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibits the Immune Evasion of Colorectal Cancer Cells by Regulating the KDM4B/HOXC4/PD-L1 Axis.
Liu L; Yu T; Jin Y; Mai W; Zhou J; Zhao C
Front Cell Dev Biol; 2021; 9():629893. PubMed ID: 33732698
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
9. LINC00511 knockdown suppresses glioma cell malignant progression through miR-15a-5p/AEBP1 axis.
Liu Z; Tao B; Li L; Liu P; Xia K; Zhong C
Brain Res Bull; 2021 Aug; 173():82-96. PubMed ID: 33992709
[TBL] [Abstract][Full Text] [Related]
10. LncRNA KCNQ1OT1 Promotes Proliferation, Invasion and Metastasis of Prostate Cancer by Regulating miR-211-5p/CHI3L1 Pathway.
Hao H; Chen H; Xie L; Liu H; Wang D
Onco Targets Ther; 2021; 14():1659-1671. PubMed ID: 33688211
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint.
Zhao L; Liu Y; Zhang J; Liu Y; Qi Q
Cell Death Dis; 2019 Sep; 10(10):731. PubMed ID: 31570691
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA KCNQ1OT1 up-regulates CTNND1 by sponging miR-329-3p to induce the proliferation, migration, invasion, and inhibit apoptosis of colorectal cancer cells.
Liu X; Zhang Y; Wang Y; Bian C; Wang F
Cancer Cell Int; 2020; 20():340. PubMed ID: 32760218
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA KCNQ1OT1 facilitates the progression of cervical cancer and tumor growth through modulating miR-296-5p/HYOU1 axis.
Liu J; Wang Y
Bioengineered; 2021 Dec; 12(1):8753-8767. PubMed ID: 34704918
[TBL] [Abstract][Full Text] [Related]
14. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p.
Sun H; Sun Y; Chen Q; Xu Z
Life Sci; 2020 Jan; 241():117161. PubMed ID: 31837329
[TBL] [Abstract][Full Text] [Related]
15. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
16. LncRNA KCNQ1OT1 promotes cell proliferation, migration and invasion via regulating miR-129-5p/JAG1 axis in non-small cell lung cancer.
Wang Y; Zhang L; Yang J; Sun R
Cancer Cell Int; 2020; 20():144. PubMed ID: 32377169
[TBL] [Abstract][Full Text] [Related]
17. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
18. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
Zhang Y; Li Y
Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
[TBL] [Abstract][Full Text] [Related]
19. KCNQ1OT1 regulates the retinoblastoma cell proliferation, migration and SIRT1/JNK signaling pathway by targeting miR-124/SP1 axis.
Zhang H; Yang X; Xu Y; Li H
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33345272
[TBL] [Abstract][Full Text] [Related]
20. CircKRT1 drives tumor progression and immune evasion in oral squamous cell carcinoma by sponging miR-495-3p to regulate PDL1 expression.
Yang Z; Chen W; Wang Y; Qin M; Ji Y
Cell Biol Int; 2021 Jul; 45(7):1423-1435. PubMed ID: 33675276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
